Skip to content
中文产业新闻评分67Chinese source

司普奇拜单抗治疗中重度结节性痒疹Ⅲ期24周数据在EADV 2026公布

24周显著改善瘙痒与皮损!司普奇拜单抗治疗成人中重度结节性痒疹Ⅲ期临床数据亮相EADV 2026!

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.